Lycera Corp - Company & Market Research Reports

Lycera is a biopharmaceutical company that is developing novel small molecule immunomodulatory medicines for the treatment of autoimmune diseases and cancer. The company offers novel oral medicines for diseases such as rheumatoid arthritis, multiple sclerosis, psoriasis, and inflammatory bowel disease. Its lead product is LYC-30937, an ATPase modulator for the treatment of inflammatory bowel disease. Lycera was founded in 2006 and is headquartered in Ann Arbor, Michigan.